top of page

INVESTOR RELATIONS

PRESS RELEASES

10/1/24

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal

24/10/23

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.

18/10/23

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

GOVERNANCE DOCUMENTS

NOTICE TO SHAREHOLDERS

SEC FILINGS

All filings for TenX Keane Acquisition available via EDGAR.

bottom of page